Supplementary Figure 1 from BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets C-Kit for the Treatment of C-Kit–driven Myeloid Leukemia
openalex（2023）
Key words
Tyrosine Kinase Inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined